ROSSARI

ROSSARI BIOTECH

Small Cap BSE: 543213 NSE: ROSSARI
₹808.00
-8.7 (-1.07%)
As on 06 December, 2022 | 12:17

Rossari Biotech Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ROSSARI BIOTECH

Start SIP

Rossari Biotech Share Price

Rossari Biotech Share Returns

  • Over 1 Month -8.87%
  • Over 3 Month -16.59%
  • Over 6 Month -7.8%
  • Over 1 Year -37.56%

Rossari Biotech Key Statistics

P/E Ratio 44.9
PEG Ratio 9.6
Market Cap Cr 4,456
Price to Book Ratio 5.5
EPS 14.2
Dividend 0.1
Relative Strength Index 41.85
Money Flow Index 31.16
MACD Signal -26.73
Average True Range 19.15

Rossari Biotech Investment Rating

  • Master Rating:
  • Rossari Biotech has an operating revenue of Rs. 1,727.49 Cr. on a trailing 12-month basis. An annual revenue growth of 108% is outstanding, Pre-tax margin of 9% is okay, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Diversified Operations and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Rossari Biotech Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 241234262269339204201
Operating Expenses Qtr Cr 213207234243301174167
Operating Profit Qtr Cr 28272726373034
Depreciation Qtr Cr 6677667
Interest Qtr Cr 1110111
Tax Qtr Cr 5656978
Net Profit Qtr Cr 15151718242021

Rossari Biotech Technicals

EMA & SMA

Current Price
810.35
-6.35 (-0.78%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 820.14
  • 50 Day
  • 860.37
  • 100 Day
  • 892.27
  • 200 Day
  • 945.61
  • 20 Day
  • 811.71
  • 50 Day
  • 877.02
  • 100 Day
  • 903.2
  • 200 Day
  • 911.37

Rossari Biotech Resistance and Support

PIVOT
₹816.99
Resistance
First Resistance 823.72
Second Resistance 830.74
Third Resistance 837.47
RSI 41.85
MFI 31.16
MACD Single Line -26.73
MACD -21.58
Support
First Resistance 809.97
Second Resistance 803.24
Third Resistance 796.22

Rossari Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 32,644 1,445,150 44.27
Week 45,193 2,333,787 51.64
1 Month 38,495 2,168,443 56.33
6 Month 56,856 2,809,279 49.41

Rossari Biotech Result Highlights

Rossari Biotech Synopsis

NSE-Diversified Operations

Rossari Biotech is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 1072.84 Cr. and Equity Capital is Rs. 11.01 Cr. for the Year ended 31/03/2022. Rossari Biotech Ltd. is a Public Limited Listed company incorporated on 10/08/2009 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH2009PLC194818 and registration number is 194818.
Market Cap 4,487
Sales 1,005
Shares in Float 1.76
No of funds 46
Yield 0.06
Book Value 5.73
U/D Vol ratio 0.5
LTDebt / Equity
Alpha -0.2
Beta 0.75

Rossari Biotech

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 68.46%68.56%68.56%
Mutual Funds 12.7%11.34%10.6%
Insurance Companies 1.32%1.52%1.52%
Foreign Portfolio Investors 8.84%8.51%9.03%
Individual Investors 6.53%6.44%6.05%
Others 2.15%3.63%4.24%

Rossari Biotech Management

Name Designation
Mr. Edward Menezes Executive Chairman
Mr. Sunil Chari Managing Director
Ms. Meher Castelino Independent Director
Mr. Goutam Bhattacharya Independent Director
Mr. Aseem Dhru Independent Director
Mr. Robin Banerjee Independent Director
Maj.Gen.(Retd.) Sharabh Pachory Independent Director

Rossari Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Rossari Biotech Corporate Action

Date Purpose Remarks
2022-11-05 Quarterly Results
2022-08-06 Quarterly Results
2022-05-19 Audited Results & Final Dividend
2022-02-14 Quarterly Results
2021-10-30 Quarterly Results

Rossari Biotech MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 26133
SBI Flexicap Fund Regular Growth 16495
SBI Small Cap Fund Regular Plan Growth 14869
UTI Unit Linked Insurance 5262
UTI Small Cap Fund Regular Growth 2386

Rossari Biotech FAQs

What is Share Price of Rossari Biotech ?

Rossari Biotech share price is ₹808 As on 06 December, 2022 | 12:03

What is the Market Cap of Rossari Biotech ?

The Market Cap of Rossari Biotech is ₹4456.3 Cr As on 06 December, 2022 | 12:03

What is the P/E ratio of Rossari Biotech ?

The P/E ratio of Rossari Biotech is 44.9 As on 06 December, 2022 | 12:03

What is the PB ratio of Rossari Biotech ?

The PB ratio of Rossari Biotech is 5.5 As on 06 December, 2022 | 12:03

Q2FY23